Dow Up 0.14% Nasdaq Up 0.23%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
8.65 Down 0.38(4.16%) 12:30PM EST - Nasdaq Real Time Price
Prev Close:9.02
Open:9.02
Bid:8.78 x 100
Ask:8.80 x 200
1y Target Est:26.83
Beta:-1.94
Next Earnings Date:N/A
Day's Range:8.62 - 9.02
52wk Range:5.92 - 22.57
Volume:158,495
Avg Vol (3m):1,422,930
Market Cap:209.87M
P/E (ttm):N/A
EPS (ttm):-1.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RPRXDown 4.16%209.87M
ABTUp 0.47%66.95B
ACTDown 0.04%71.66B
AUXLUp 1.10%1.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.38
Quarterly EPS Est (Dec-14) :-0.31
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback